Sign in
Taking people in United StatesNo phase

Tests potato starch fiber in people with diabetes and heart failure

Tests potato starch added to diet in adults with diabetes and heart failure.

Key facts

Who runs it
University of Michigan
Where
Ann Arbor, United StatesSee the site
Trial code
Registry title
Fiber Supplementation in Heart Failure With Preserved Ejection Fraction (HFpEF)
Status
Recruiting
People taking part
30 people, planned
Started
1 Apr 2024
Expected to end
Dec 2026
Type of study
Interventional
Treatments tested
  • Potato Starch
Record updated
24 July 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with stable heart failure with preserved ejection fraction (HFpEF) and type 2 diabetes. It studies whether adding potato starch to the diet changes gut bacteria.

Age
18 years or older
Sex
All sexes can join.
Disease stage
Stable HFpEF on the highest heart failure medicines the person can tolerate, with no dose change in the past month. Left ventricular ejection fraction above 50% in the past 12 months. Type 2 diabetes with glycated hemoglobin below 10% (86 mmol/mol), with no change in diabetes treatment in the past month.
Earlier treatment
People cannot have taken antibiotics in the past 6 months. They cannot currently use prebiotics or probiotics.
Biomarker or test result
Glycated hemoglobin below 10% (86 mmol/mol). Left ventricular ejection fraction above 50%.

Main reasons for not taking part

  • Antibiotics in the past 6 months
  • Current use of prebiotics or probiotics
  • Potato or potato starch allergy
  • Bowel disease, bowel surgery, celiac disease or colorectal cancer
  • Stage IV-V chronic kidney disease

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • A confirmed clinical diagnosis of stable HFpEF on maximally tolerated Heart Failure (HF) medical regimen (without changes in dosage in the prior month)
  • Left ventricular ejection fraction of >50% documented in the prior 12 months
  • A confirmed clinical diagnosis of Type II diabetes (T2DM) with glycated hemoglobin <10% without changes in medical regimen in the past month

Who cannot take part

  • History of potato allergy or potato starch allergy, inflammatory bowel syndrome, inflammatory bowel disease, bowel resection, Roux-en-Y gastric bypass surgery, celiac disease, Crohn's disease, or colorectal cancer
  • Stage IV-V chronic kidney disease
  • Hypoglycemic episode with blood glucose 70 milligrams per deciliter (mg/dL) within the last month
  • Current usage of pre- or probiotic usage
  • Antibiotic usage in the past 6 months
  • Current participation in another interventional clinical trial
  • Pregnancy (self-reported)
  • Comorbidity limiting survival to < 12 months

Where in United States

  • University of MichiganAnn Arbor, United StatesContact: Hayley Billingsley, PhDTaking people

About the trial

What the trial wants to find out

The study team is studying how increasing dietary fiber, specifically through adding potato starch to participant's diet, may impact the species of bacteria in participant's gut microbiome. The study team also wants to understand if adding potato starch to participant's diet helps these bacteria make more short chain fatty acids, a byproduct the team thinks may benefit participant's health.

The group in the trial

  • Potato starch supplementTreatment being tested

    Participants will take the supplement for approximately 4 weeks.

    Treatment: Potato Starch

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Fiber Supplementation to Increase Short Chain Fatty Acid Production in Patients With Type II Diabetes and Heart Failure With Preserved Ejection Fraction - the FERMENT HFpEF Trial
Plain-language title
Tests potato starch fiber in people with diabetes and heart failureGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
24 July 2025